Global Endocrinology Drugs Market by Type (Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs), By Application (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The global endocrinology drugs market reached USD 3.5 billion in 2017 and is expected to reach USD 6.2 billion by 2028, growing at a CAGR of 7.9% during the forecast period from 2021-2028. Diabetes drugs accounted for the largest share of this market in 2017 with about 30%, followed by testosterone replacement drugs (19%), human growth hormone (HGH) drugs (14%), thyroid hormone disorder drugs (11%). North America dominated this market accounting for more than 40% share of the total revenues in 2017 as compared to Europe and the Asia Pacific which accounted mainly due to their high healthcare spending rates and large population size respectively.
Endocrinology drugs are medicines that affect the endocrine system and help manage certain medical conditions. Examples of these types of drugs include thyroid hormone disorder drugs, diabetes medications, human growth hormones (HGH), testosterone replacement therapy medication, etc. These treatments can be used in hospitals or ambulatory care centers to treat a number of health problems including hormonal imbalances caused by diseases like hypothyroidism and adrenal insufficiency.
On the basis of type, endocrinology drugs are segmented into diabetes drugs, testosterone replacement therapy medications, human growth hormone (HGH), and thyroid hormone disorder medicines.
Diabetes Drugs
Diabetes endocrinology drugs are a type of pharmaceuticals that manage the disorder by controlling blood glucose levels. These diabetes endocrinology drugs have been shown to be more effective than insulin itself in managing Type Two Diabetes, particularly when combined with exercise and diet changes.
Testosterone replacement therapy medications
Testosterone replacement therapy medications are drugs that replace the male hormone, testosterone. Testosterone is produced by the testicles in males and released into the bloodstream where it travels to cells throughout the body. They are the drugs that can be used to treat testosterone deficiency. Testosterone is a male sex hormone and helps control sexual function, body hair, muscle mass, red cell production in the blood, and sperm production for men. Low levels of this hormone may lead to symptoms such as low libido (sex drive), difficulty achieving an erection adequate for penetrative intercourse, or infertility.
Human Growth Hormone (HGH)
HGH endocrine drugs are medications that act on certain hormones in the body to stimulate growth. The three most common types of HGH endocrine drugs are Growth hormone replacement therapy, human growth hormone deficiency (or GH-D), and pediatric cases with insufficient endogenous production of human growth hormone. There is a growing need for treatment as many individuals develop diseases related to age or other factors which can lead to decreased levels of natural HGH secretion.
Thyroid Hormone Disorder Medicines
Thyroid hormone disorder medicines are medications that help in the management of thyroid disorders. It includes synthetic hormones such as thyroxine and liothyronine, which replace or supplement the deficient levels in patients suffering from low production of these hormones due to thyroid gland diseases; radioactive iodine therapy; antithyroid drugs for prevention and treatment of hyperthyroidism (excess secretion by the thyroid) and hypothyroidism (deficient secretion by the thyroid).
On the basis of application, endocrinology drugs are segmented into hospitals, commercial laboratories, and other settings.
Hospitals
Endocrinology drugs are used in hospitals for the treatment of disorders related to hormones, such as diabetes and thyroid hormone disorder. Hospitals typically use specific endocrinology drug types depending on factors like their type and size. For instance, large hospitals may require more advanced medication than smaller ones because they have a greater capacity to manage patients with complex medical conditions.
Commercial Laboratories
Endocrinology drugs are used in commercial laboratories to provide a personalized treatment plan for patients. In this way, endocrinologists can monitor the effects of different medications and determine any side effects or reactions from treatments in order to prescribe an appropriate dosage. Most of the endocrinology drugs are used in hospitals and other settings. However, some of them are also being commonly found in commercial laboratories for research purposes or to prepare medications for future use.
Other Settings
The other setting includes self-medication centers, university hospitals, and clinics, polyclinics, or general practitioners.
On the basis of region, the global endocrinology drugs market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the global endocrinology drugs market due to the higher availability of advanced healthcare facilities in this region. The U.S., with its large population size, is a major contributor to the North American segmentation of the endocrinology drugs market. In addition, Canada has also emerged as an important country contributing towards increment in demand for specialty hospitals which are mainly focused on diabetes care management
Asia-Pacific is projected to grow at the fastest CAGR during the forecast period owing to increasing awareness about obesity among people coupled with improving economic conditions that have led to increased healthcare expenditure across Asia Region.
Growth Factors
The global endocrinology drugs market has witnessed significant growth in the past few years. The surging populations of obese and diabetic patients are likely to increase demand for diabetes-related drug treatments while raising awareness about hormonal imbalance disorders also supports the growth of this market. Rising awareness about gene therapy as an effective treatment option is expected to create opportunities for various pharmaceutical companies between 2018 and 2028.
Up Market Research published a new report titled “Endocrinology Drugs Market research report which is segmented by Types (Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs), By Applications (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting), By Players/Companies AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi”. As per the study, the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Endocrinology Drugs Market Research Report |
| By Type | Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs |
| By Application | Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting |
| By Companies | AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 208 |
| Number of Tables & Figures | 146 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Endocrinology Drugs Market Report Segments:
The market is segmented by Type Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs and By Application Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting.
Some of the companies that are profiled in this report are:
- AbbVie
- AstraZeneca
- Eli Lilly
- Merck
- Novo Nordisk
- Sanofi
Endocrinology Drugs Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Endocrinology Drugs Market
Overview of the regional outlook of the Endocrinology Drugs Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Endocrinology Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Endocrinology Drugs Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Diabetes Drugs
2. Testosterone Replacement Drugs
3. Human Growth Hormone Drugs
4. Thyroid Hormone Disorder Drugs
7. By Application:1. Hospitals
2. Commercial Laboratories
3. Ambulatory Care Centres
4. Other Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endocrinology Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Endocrinology Drugs Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrinology Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endocrinology Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endocrinology Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endocrinology Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endocrinology Drugs Market Size & Forecast, 2018-2028
4.5.1 Endocrinology Drugs Market Size and Y-o-Y Growth
4.5.2 Endocrinology Drugs Market Absolute $ Opportunity
Chapter 5 Global Endocrinology Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Endocrinology Drugs Market Size Forecast by Type
5.2.1 Diabetes Drugs
5.2.2 Testosterone Replacement Drugs
5.2.3 Human Growth Hormone Drugs
5.2.4 Thyroid Hormone Disorder Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Endocrinology Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Endocrinology Drugs Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Commercial Laboratories
6.2.3 Ambulatory Care Centres
6.2.4 Other Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endocrinology Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endocrinology Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Endocrinology Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Endocrinology Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Endocrinology Drugs Market Size Forecast by Type
9.6.1 Diabetes Drugs
9.6.2 Testosterone Replacement Drugs
9.6.3 Human Growth Hormone Drugs
9.6.4 Thyroid Hormone Disorder Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Endocrinology Drugs Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Commercial Laboratories
9.10.3 Ambulatory Care Centres
9.10.4 Other Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Endocrinology Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Endocrinology Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Endocrinology Drugs Market Size Forecast by Type
10.6.1 Diabetes Drugs
10.6.2 Testosterone Replacement Drugs
10.6.3 Human Growth Hormone Drugs
10.6.4 Thyroid Hormone Disorder Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Endocrinology Drugs Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Commercial Laboratories
10.10.3 Ambulatory Care Centres
10.10.4 Other Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Endocrinology Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Endocrinology Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Endocrinology Drugs Market Size Forecast by Type
11.6.1 Diabetes Drugs
11.6.2 Testosterone Replacement Drugs
11.6.3 Human Growth Hormone Drugs
11.6.4 Thyroid Hormone Disorder Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Endocrinology Drugs Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Commercial Laboratories
11.10.3 Ambulatory Care Centres
11.10.4 Other Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Endocrinology Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Endocrinology Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Endocrinology Drugs Market Size Forecast by Type
12.6.1 Diabetes Drugs
12.6.2 Testosterone Replacement Drugs
12.6.3 Human Growth Hormone Drugs
12.6.4 Thyroid Hormone Disorder Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Endocrinology Drugs Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Commercial Laboratories
12.10.3 Ambulatory Care Centres
12.10.4 Other Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Endocrinology Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Type
13.6.1 Diabetes Drugs
13.6.2 Testosterone Replacement Drugs
13.6.3 Human Growth Hormone Drugs
13.6.4 Thyroid Hormone Disorder Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Commercial Laboratories
13.10.3 Ambulatory Care Centres
13.10.4 Other Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endocrinology Drugs Market: Competitive Dashboard
14.2 Global Endocrinology Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 AstraZeneca
14.3.3 Eli Lilly
14.3.4 Merck
14.3.5 Novo Nordisk
14.3.6 Sanofi
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrinology Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endocrinology Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endocrinology Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endocrinology Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endocrinology Drugs Market Size & Forecast, 2018-2028
4.5.1 Endocrinology Drugs Market Size and Y-o-Y Growth
4.5.2 Endocrinology Drugs Market Absolute $ Opportunity
Chapter 5 Global Endocrinology Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Endocrinology Drugs Market Size Forecast by Type
5.2.1 Diabetes Drugs
5.2.2 Testosterone Replacement Drugs
5.2.3 Human Growth Hormone Drugs
5.2.4 Thyroid Hormone Disorder Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Endocrinology Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Endocrinology Drugs Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Commercial Laboratories
6.2.3 Ambulatory Care Centres
6.2.4 Other Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endocrinology Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endocrinology Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Endocrinology Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Endocrinology Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Endocrinology Drugs Market Size Forecast by Type
9.6.1 Diabetes Drugs
9.6.2 Testosterone Replacement Drugs
9.6.3 Human Growth Hormone Drugs
9.6.4 Thyroid Hormone Disorder Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Endocrinology Drugs Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Commercial Laboratories
9.10.3 Ambulatory Care Centres
9.10.4 Other Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Endocrinology Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Endocrinology Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Endocrinology Drugs Market Size Forecast by Type
10.6.1 Diabetes Drugs
10.6.2 Testosterone Replacement Drugs
10.6.3 Human Growth Hormone Drugs
10.6.4 Thyroid Hormone Disorder Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Endocrinology Drugs Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Commercial Laboratories
10.10.3 Ambulatory Care Centres
10.10.4 Other Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Endocrinology Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Endocrinology Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Endocrinology Drugs Market Size Forecast by Type
11.6.1 Diabetes Drugs
11.6.2 Testosterone Replacement Drugs
11.6.3 Human Growth Hormone Drugs
11.6.4 Thyroid Hormone Disorder Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Endocrinology Drugs Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Commercial Laboratories
11.10.3 Ambulatory Care Centres
11.10.4 Other Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Endocrinology Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Endocrinology Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Endocrinology Drugs Market Size Forecast by Type
12.6.1 Diabetes Drugs
12.6.2 Testosterone Replacement Drugs
12.6.3 Human Growth Hormone Drugs
12.6.4 Thyroid Hormone Disorder Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Endocrinology Drugs Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Commercial Laboratories
12.10.3 Ambulatory Care Centres
12.10.4 Other Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Endocrinology Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Type
13.6.1 Diabetes Drugs
13.6.2 Testosterone Replacement Drugs
13.6.3 Human Growth Hormone Drugs
13.6.4 Thyroid Hormone Disorder Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Commercial Laboratories
13.10.3 Ambulatory Care Centres
13.10.4 Other Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endocrinology Drugs Market: Competitive Dashboard
14.2 Global Endocrinology Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 AstraZeneca
14.3.3 Eli Lilly
14.3.4 Merck
14.3.5 Novo Nordisk
14.3.6 Sanofi
Segments Covered in the Report
The global Endocrinology Drugs market has been segmented based on
By Types
The global Endocrinology Drugs market has been segmented based on
By Types
- Diabetes Drugs
- Testosterone Replacement Drugs
- Human Growth Hormone Drugs
- Thyroid Hormone Disorder Drugs
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centres
- Other Setting
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- AbbVie
- AstraZeneca
- Eli Lilly
- Merck
- Novo Nordisk
- Sanofi
Our Clients
Related Reports
Some other reports from this category!
